Related Image: Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance |
(Date:11/25/2009)...ewswire/--WhenmostpeopleheartheacronymTMJ,theythin...sthehelptheyneed.TMJstandsfortheTemporal-Mandibula...ctswithyourskull(temporalbone). ,, Themostcommo...ewing,clickingorpoppingofthejaw.Butmanyothersympto...,fatigue,sleepdisturbances,irritability,alossinfoc...
(Date:11/25/2009)...elleMedicalInc.,aleadingmanufacturerofbreastMRIcoi...newleadingedgeclinicalapplicationsonitsAegis(TM)me...alSocietyofNorthAmerica(RSNA)annualmeetinginChicag...nsleveragetheuniquehighqualityimagesgeneratedbySen...pleimagingmodalitiesformulti-parametricassessment....
(Date:11/25/2009)...TheBayAreaAirQualityManagementDistrictisissuingthe...rt forThursday,November26,2009whichbansburningwo...oorsandoutdoors. ,, "Cold,stillweatherwillcontr...ent,executiveofficeroftheAirDistrict."We,reaskingB...ndfellowcommunitymembersthisThanksgiving,andnottob...
(Date:11/25/2009)...of a collaboration between UCLA engineers and phys...10 million Americans who suffer from peripheral ar... the arteries, peripheral arterial disease, or PAD...d arteries reduce blood flow to the limbs. The con...se, heart attack and stroke, and its progression c...
(Date:11/25/2009)...treatment clinics to resume Monday, Nov. 30 , ..., 2009 -- Centegra Health System is continuing to ...t four Centegra Primary Care (CPC) vaccination cli.... The clinics are at CPC sites in Huntley, Woodsto...ollows: , From 4:30 to 7:30 p.m. Tue...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4...tial financial income and the c...ime is a precious commodity, and so,people are inc... their,time, especially when it comes to financial...rgest online and catalog companies catering,exclus...
...ior Management Team, NASHVILLE, Tenn., May 20 Em...nue cycle management and clinical communication,so...as been named Senior,Vice President of Corporate S...ntly, Ms. Paramore was a,Partner with Commonwealth...
...fits of,lipid-modifying drugs, current management ...n a new supplement to The Journal of Family,Practi... in aggressive,lipid lowering" reviews the evidenc... patients., "High-dose statin therapy: Benefits a...
...in key organs , , TUESDAY, May 20 (HealthD...lso protect against adenovirus, which causes upper...uses that causes the common cold. , Currently, the...hing that needs to be done before new drugs can be...
...oomers,have challenged many industries to replace ...the multi-generational workforce is challenging,co...s to engage employees,and to define a new type of ...long,term strategies through dynamic case study pr...
...s with latent tuberculosis (TB), who are infected ...t it in less than half the time and at a lower cos...o researchers who conducted a multi-center, random... We found that using a therapy of four months of R...
Other Medicine News:Health News:Lucrative Sales Opportunities Abound With Melaleuca, The Wellness Company(R) 2Health News:Emdeon Business Services Names Miriam Paramore Senior Vice President of Corporate Strategy 2Health News:Reductions in CV Morbidity and Mortality are Achievable! 2Health News:Smallpox Drug May Protect Against Common Cold 2Health News:Fortune 500s to Convene in Florida, Sharing Insights & Best Practices for Developing Tomorrow's Leaders 2Health News:Rifampin: Latent TB treatment saves time money and lives 2(Date:11/25/2009)...swire/--AccordingtoMillenniumResearchGroup(MRG),th...nce,thenearly$3billionUSmarketfortraumafixationdev...rsdespitetherecenteconomicslowdown.MRG,s USMarkets...llremainhighlydynamicoverthenextfiveyears,withcomp...derservedsegmentsofthetraumafixationmarket,fueling...
(Date:11/25/2009)...ANNESBURG,November25/PRNewswire/--,iThembaPharmace...oday,thattheyhavesignedacollaborativeagreementtojo...worldclasscomputationalchemistryandleaddiscoveryex...oprovidemedicinaland,syntheticchemistrysupporttopr...etwork.iThembaPharmaceuticalsandPyxisDiscovery,als...
(Date:11/24/2009)...swire-FirstCall/--Endologix,Inc.(Nasdaq: ELGX ),de...ders,announcedtodaythatithasfiledamotiontostay,ord...wsuitbroughtagainstitinOctober2009byCook,Inc.Themo...apolis,Indiana. ,, Endologixhasrequestedthatthe...demarkOffice(USPTO)conductsproceedingstore-examine...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2BioFit Intensive Plus 26amp 3B 238482 3B Chairs Meet Federal Standard for Continuous Intensive Use 48720 1BioFit Intensive Plus 26amp 3B 238482 3B Chairs Meet Federal Standard for Continuous Intensive Use 48720 2BioFit Intensive Plus 26amp 3B 238482 3B Chairs Meet Federal Standard for Continuous Intensive Use 48720 3Manatees can probably hear which directions boats approach from 8808 1Manatees can probably hear which directions boats approach from 8808 2Hey Governator 21 Dont Terminate Senior Funding 21 48717 1Hey Governator 21 Dont Terminate Senior Funding 21 48717 2Hey Governator 21 Dont Terminate Senior Funding 21 48717 3Hey Governator 21 Dont Terminate Senior Funding 21 48717 4Hey Governator 21 Dont Terminate Senior Funding 21 48717 5...t, a division of Rigaku,Americas Corporation, anno...-based Lead Discovery (FBLD) Project with CHDI, In..."fragments," to the,active sites of protein drug t...mpounds used in traditional high-throughput screen...hemical space with a smaller screening,library. Ut...
...,multi-disciplinary group of researchers from the ...rsity of Maryland Biotechnology Institute (UMBI),h...Foundation (NSF) grant,to revolutionize the way re... The group, led by William Bentley, Herbert Rabin ...Department of Bioengineering at the,University of ...
Other Medicine Technology:ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies 2ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies 3U. of Md. Researchers to Develop Devices to Revolutionize Drug Research 2U. of Md. Researchers to Develop Devices to Revolutionize Drug Research 3U. of Md. Researchers to Develop Devices to Revolutionize Drug Research 4U. of Md. Researchers to Develop Devices to Revolutionize Drug Research 5RIDASCREEN Anti-VZV IgM Assay
...ricella- Zoster Virus (VZV) IgG Enzyme- linked Imm...tion and quantitative determination of IgG antibod... may be used for the determination of immune statu...d to demonstrate seroconversion or a significant r...
...nzyme-Linked Immunosorbent Assay (ELISA) is intend...n of IgG antibody to VZV in human sera. Individua...n of immune status. Paired sera, acute and convale...r a significant rise in antibody level, as an aid ...
RIDASCREEN Anti-Mumps Virus IgM Assay
Medicine Products: